Modern obstetric ultrasound has allowed a detailed evaluation of many fetal small arteries in both normal and abnormal conditions. Recently, a study of a very tiny fetal coronary artery has been proved possible when the imaging condition is optimal (Baschat et al., 1997). An augmentation of fetal coronary blood flow reflecting an attempt to compensate for an increase in oxygen demand by means of autoregulation process has been demonstrated with Doppler ultrasound in both acute and chronic fetal stress conditions such as acute fetomaternal hemorrhage, fetal ductal constriction, and intrauterine growth restriction (IUGR) (Baschat et al., 2003). We present herein the first case of coronary blood flow enhancement in a fetus with supraventricular tachycardia (SVT) demonstrated with Doppler ultrasound. The evidence of the enhancement of blood flow disappeared when the fetal heart rate was eventually converted to normal sinus rhythm with maternal ingestion of flecainide.A 26-year-old pregnant woman, gravida 1, was referred to our high-risk pregnancy clinic at 29 weeks' gestation for a rapid fetal heart rate detected at prenatal clinic. Our sonographic examination revealed a fetal biometry consistent with gestational age. No structural anomaly was noted. Fetal echocardiography demonstrated a normal cardiac anatomy. A rapid heart rate of 220-240 bpm with 1-to-1 atrioventricular conduction was noted in M-mode. Color Doppler ultrasound clearly demonstrated a holosystolic tricuspid regurgitation and a prominent coronary blood flow (Figure 1a). Spectral Doppler showed an increased inferior vena cava (IVC) reversed flow at atrial contraction and an intact ductus venosus waveform. A biphasic coronary waveform with a diastolic peak flow of 45.5 cm/s was noted ( Figure 1b). Fetal SVT was diagnosed and the fetus was initially treated with maternal ingestion of digoxin. The fetal heart rate resisted converting to sinus rhythm after 5 days when maternal digitalis level reached the therapeutic range of 1.2 ng/mL.Treatment was then switched to oral flecainide. In view of drug-to-drug interaction, the proarrhythmic effect of flecainide as well as the small habitus of our patient, we initially started with a dosage of 200 mg/day. Fetal heart rate was gradually slowing down to around 180-190 bpm on the following day and eventually turned completely to normal sinus rhythm 4 days later when flecainide was increased to 300 mg/day. A Doppler ultrasound study at this time of 31 weeks' gestation revealed a normalization of IVC waveform and disappearance of tricuspid regurgitation. Moreover, the coronary perfusion previously recognized could no longer be demonstrated. Weekly monitoring revealed a consistent normal sinus rhythm and a reappearance of coronary blood flow with diastolic and systolic velocity of 34 and 22 cm/s respectively at 33 weeks' gestation. The patient had regular prenatal visits thereafter until 36 weeks' gestation when she eventually developed premature rupture of membranes and severe pre-eclampsia. A low transverse cesarean...